{"id":"https://openalex.org/W1368189","doi":null,"title":"Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.","display_name":"Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.","publication_year":2003,"publication_date":"2003-09-01","ids":{"openalex":"https://openalex.org/W1368189","mag":"1368189","pmid":"https://pubmed.ncbi.nlm.nih.gov/14704484"},"language":"en","primary_location":{"id":"pmid:14704484","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14704484","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108585219","display_name":"J\u00f3zefa W\u0119sierska\u2010G\u0105dek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"J\u00f3zefa Wesierska-Gadek","raw_affiliation_strings":["Cell Cycle Regulation Group, Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. Jozefa.Antonia.Gadek-Wesierski@univie.ac.at"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Cycle Regulation Group, Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. Jozefa.Antonia.Gadek-Wesierski@univie.ac.at","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055883188","display_name":"Marieta Gueorguieva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marieta Gueorguieva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032595342","display_name":"Marcel Hork\u00fd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcel Horky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9999,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.84922745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"55","issue":"5","first_page":"895","last_page":"902"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/roscovitine","display_name":"roscovitine","score":1.0},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9110000133514404},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9559999704360962},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7680000066757202},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":1.0},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.7419999837875366},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9589999914169312},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cdk5","display_name":"cyclin-dependent kinase 5","score":0.8080000281333923},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.6710000038146973},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.8881289958953857},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.625054657459259},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.6211749315261841},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5620058178901672},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5152474045753479},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.5053043961524963},{"id":"https://openalex.org/C121738310","wikidata":"https://www.wikidata.org/wiki/Q18248262","display_name":"Cyclin-dependent kinase 5","level":5,"score":0.464496374130249},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.43832144141197205},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.4330430030822754},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.42036861181259155},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.3763771057128906},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36491239070892334},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3084340989589691},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24013644456863403}],"mesh":[{"descriptor_ui":"D000077546","descriptor_name":"Roscovitine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016195","descriptor_name":"G2 Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051360","descriptor_name":"Cyclin-Dependent Kinase 5","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:14704484","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14704484","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.377.7873","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.377.7873","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rabbit.if-pan.krakow.pl/pjp/pdf/2003/5_895.pdf","raw_type":"text"},{"id":"mag:1368189","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14704484","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W97735725","https://openalex.org/W1511058669","https://openalex.org/W1596758412","https://openalex.org/W1610470214","https://openalex.org/W1680614702","https://openalex.org/W1741860215","https://openalex.org/W1944970393","https://openalex.org/W1965260678","https://openalex.org/W1965769778","https://openalex.org/W1971140803","https://openalex.org/W1974007211","https://openalex.org/W1978479372","https://openalex.org/W1999248906","https://openalex.org/W2024036471","https://openalex.org/W2025963365","https://openalex.org/W2043497955","https://openalex.org/W2045563337","https://openalex.org/W2083280703","https://openalex.org/W2088445980","https://openalex.org/W2103231366","https://openalex.org/W2135129680","https://openalex.org/W2147349955","https://openalex.org/W2165382714","https://openalex.org/W2312795792","https://openalex.org/W2316434439","https://openalex.org/W2317786914","https://openalex.org/W2319148198","https://openalex.org/W4232613545"],"related_works":["https://openalex.org/W2132789732","https://openalex.org/W7101142478","https://openalex.org/W2053372213","https://openalex.org/W2002448561","https://openalex.org/W2135129680","https://openalex.org/W2315073299","https://openalex.org/W169333046","https://openalex.org/W2158665741","https://openalex.org/W4229544604","https://openalex.org/W3044221865"],"abstract_inverted_index":{"Cyclin-dependent":[0],"kinases":[1],"(CDKs)":[2],"have":[3],"recently":[4],"raised":[5],"considerable":[6],"interest":[7],"in":[8,14,32,66,105,127,133],"view":[9],"of":[10,17,42,50,74,99,118,125,162,171,180,200,205,214,222,245],"their":[11,54,153],"key":[12],"role":[13],"the":[15,18,36,43,72,89,95,123,168,223,243],"regulation":[16],"cell":[19,44,157,197],"cycle":[20,158,198],"progression.":[21,159],"In":[22],"proliferating":[23],"cells,":[24],"distinct":[25,51],"CDKs":[26,52,70,126,141,176],"associated":[27],"with":[28,71,178,218,226],"specific":[29],"cyclins":[30],"coordinate":[31],"an":[33],"orchestrated":[34],"way":[35],"appropriate":[37],"transition":[38],"between":[39],"different":[40],"phases":[41],"cycle.":[45],"Mutations":[46],"and/or":[47],"aberrant":[48],"expression":[49],"and":[53,61,108,116,132,196,241],"regulatory":[55,97],"components":[56],"lead":[57],"to":[58,63,88,93,110,152,155,166,231],"uncontrolled":[59],"proliferation":[60,195,244],"finally":[62],"carcinogenesis.":[64],"However,":[65],"post-mitotic":[67],"neurons,":[68],"all":[69],"exception":[73],"CDK5":[75,101],"are":[76],"silent.":[77],"CDK5,":[78],"a":[79,84,137,174,219],"proline-directed":[80],"serine/threonine":[81],"kinase":[82],"exhibiting":[83],"close":[85],"structural":[86],"homology":[87],"mitotic":[90],"CDKs,":[91],"binds":[92],"p35,":[94],"neuron-specific":[96],"subunit":[98],"CDK5.":[100],"is":[102],"very":[103],"abundant":[104],"mature":[106],"neurons":[107,128],"seems":[109],"regulate":[111],"neurotransmitter":[112],"release":[113],"through":[114],"phosphorylation":[115],"down-regulation":[117],"calcium":[119],"channel":[120],"activity.":[121],"Therefore,":[122],"inhibition":[124],"after":[129,212],"oxidative":[130],"stress":[131],"neurodegenerative":[134],"disorders":[135],"has":[136],"protective":[138],"action.":[139,233],"Selective":[140],"inhibitors":[142],"were":[143],"developed":[144],"as":[145],"promising":[146],"drugs":[147],"for":[148],"cancer":[149,186],"therapy":[150],"due":[151],"ability":[154],"arrest":[156],"The":[160],"aim":[161],"this":[163],"study":[164],"was":[165],"compare":[167],"anti-proliferative":[169],"effect":[170,193],"roscovitine":[172],"(ROSC),":[173],"potent":[175],"inhibitor,":[177],"that":[179,236],"cisplatin":[181],"(CP)":[182],"on":[183,194],"human":[184,246],"breast":[185,247],"MCF-7":[187,201,229],"cells.":[188,249],"ROSC":[189,215,237],"exerted":[190],"stronger":[191],"inhibitory":[192],"progression":[199],"than":[202],"CP.":[203],"Accumulation":[204],"G(2)/M":[206],"arrested":[207],"cells":[208,230],"starting":[209],"6":[210],"h":[211],"onset":[213],"treatment":[216],"coincided":[217],"strong":[220],"up-regulation":[221],"p53.":[224],"Reconstitution":[225],"caspase-3":[227],"sensitized":[228],"CP":[232],"It":[234],"implicates":[235],"inhibits":[238],"more":[239],"selectively":[240],"efficaciously":[242],"carcinoma":[248]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}